Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Gastroenterology

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2000.02081.xPMID 10950039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Genetics of pancreatic cancer. From genes to families.

  1998cited by this paper
• Prognostic factors in ductal pancreatic cancer

  1998cited by this paper
• Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma.

  1997cited by this paper
• Lymph node micrometastases from breast carcinoma

  1997cited by this paper
• Detection of Mutant K‐ras in Dissected Paraaortic Lymph Nodes of Patients with Pancreatic Adenocarcinoma

  1997cited by this paper
• Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• Pancreatic nodal metastases: biologic significance and therapeutic considerations.

  1996cited by this paper
• Results of extensive surgery for pancreatic carcinoma

  1996cited by this paper
• Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

  1996influential reference
• Detection of ras Gene Mutations in Perioperative Peripheral Blood with Pancreatic Adenocarcinoma

  1996cited by this paper
• Genetic diagnosis of lymph-node metastasis in colorectal cancer.

  1995cited by this paper
• A sensitive and high-resolution method for the detection of mutations in the p53 gene using fluorescence-based PCR-SSCP

  1995cited by this paper
• Long-term survival following pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas.

  1995cited by this paper
• Detection of Hepatic Micrometastasis in Pancreatic Adenocarcinoma Patients by Two‐stage Polymerase Chain Reaction/Restriction Fragment Length Polymorphism Analysis

  1995cited by this paper
• Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.

  1994cited by this paper
• K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

  1994cited by this paper
• Mutation of the p53 gene in gallbladder cancer.

  1994cited by this paper
• p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

  1994cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas

  1994cited by this paper
• Point mutation of K-ras gene codon 12 in biliary tract tumors.

  1994cited by this paper
• Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.

  1993influential reference
• Detection of K‐ras mutation in sputum by mutant‐allele‐specific amplification (MASA)

  1993cited by this paper
• Pancreatic adenocarcinomas frequently show p53 gene mutations.

  1993cited by this paper
• Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma.

  1992cited by this paper
• Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.

  1991cited by this paper
• Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

  1991cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Activated ras genes in human seminoma: evidence for tumor heterogeneity.

  1989cited by this paper
• Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head

  1988cited by this paper
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

  1988cited by this paper
• A variation in the structure of the protein-coding region of the human p53 gene.

  1988cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Activation of c-Ki-ras gene in human pancreatic cancer.

  1985cited by this paper

• Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients

  2020cites this paper
• Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool?

  2018cites this paper
• Systematic review of the clinical significance of lymph node micrometastases of pancreatic adenocarcinoma following surgical resection.

  2017cites this paper
• Adverse reaction of a combined treatment for unresectable liver cancer

  2014cites this paper
• A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.

  2012cites this paper
• Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

  2011cites this paper
• Nachweis hepatischer Mikrometastasen

  2010cites this paper
• Correlations Between p53 Gene Mutations and Histologic Characteristics of Pancreatic Ductal Carcinoma

  2009cites this paper
• Pancreatic cancer: a generalized disease—prognostic impact of cancer cell dissemination

  2008cites this paper
• Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.

  2007cites this paper
• Comparative evaluation of p53 mutation in pancreatic adenocarcinoma and chronic pancreatitis.

  2006cites this paper
• Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients

  2006cites this paper
• Impact of disseminated tumor cells in gastrointestinal cancer

  2006cites this paper
• [Significance of occult lymphatic tumor spread in pancreatic cancer].

  2005cites this paper
• Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significance.

  2005cites this paper
• Okkulte lymphatische Tumorzelldisseminierung beim Pankreaskarzinom

  2005cites this paper
• Clinical significance of k-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis

  2005cites this paper
• Detection of disseminated tumour cells in the liver of cancer patients.

  2005cites this paper
• 3 - Molecular Detection of Micrometastases in Pancreatic Cancer

  2005cites this paper
• MOLECULAR DETECTION OF METASTASES IN REGIONAL LYMPH NODES IN PATIENTS WITH CANCER OF THE HEAD OF THE PANCREAS. CLINICAL RELEVANCE.

  2004cites this paper
• DETECTION OF OCCULT LYMPH NODE METASTATIC CARCINOMA BY IMMUNOHISTOCHEMICAL METHODAND CYTOKERATIN MARKER

  2004cites this paper
• TGF-β and p53 Staining in CT-Guided and Endoscopic Ultrasound Fine-Needle Aspirates of Pancreatic Adenocarcinoma

  2004cites this paper
• Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic Cancer

  2003cites this paper
• Micrometastases from HBP malignancies and metastatic cancer.

  2002cites this paper
• Sentinel lymph node evaluation for tumor metastasis.

  2002cites this paper
• [Value of cytokeratin and Ca 19-9 antigen in immunohistological detection of disseminated tumor cells in lymph nodes in pancreas carcinoma].

  2001cites this paper
• Role of p53 mutations on survival after pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head.

  2001cites this paper
• Frequency of Prevalence of K−ras , p16 and p53 Genes Mutations and c−erbB−2 Amplification in Patients Operated Because of Pancreatic Cancer and Chronic Pancreatitis

  year unknowncites this paper